These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12921253)

  • 41. Bone tissue and plasma concentrations of linezolid and vancomycin in rabbits with prosthesis-related infection due to MRSA.
    Swoboda S; Helbig L; Kommerell M; Simank HG; Kees F; Geiss HK; Hoppe-Tichy T; Schröder K
    Pharmazie; 2009 Jun; 64(6):407-9. PubMed ID: 19618680
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
    Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
    Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ocular penetration of topically applied linezolid in a rabbit model.
    Saleh M; Jehl F; Dory A; Lefevre S; Prevost G; Gaucher D; Sauer A; Speeg-Schatz C; Bourcier T
    J Cataract Refract Surg; 2010 Mar; 36(3):488-92. PubMed ID: 20202550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Penetration of linezolid into the anterior chamber (aqueous humor) of the human eye after intravenous administration.
    Vázquez EG; Mensa J; López Y; Couchard PD; Soy D; Fontenla JR; Sarasa M; Carné X; Montull E
    Antimicrob Agents Chemother; 2004 Feb; 48(2):670-2. PubMed ID: 14742235
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
    Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
    Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Linezolid and continuous venovenous hemofiltration.
    Meyer B; Thalhammer F
    Clin Infect Dis; 2006 Feb; 42(3):435-6; author reply 437-8. PubMed ID: 16392097
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.
    Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Sakamoto S; Morita K; Yukawa E; Kamimura H; Karube Y
    Scand J Infect Dis; 2012 Aug; 44(8):626-9. PubMed ID: 22263918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient.
    Pea F; Scudeller L; Lugano M; Baccarani U; Pavan F; Tavio M; Furlanut M; Rocca GD; Bresadola F; Viale P
    Clin Infect Dis; 2006 Feb; 42(3):434-5. PubMed ID: 16392096
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
    Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
    Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
    Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elimination of linezolid by an in vitro extracorporeal circuit model.
    Schroeder TH; Hansen M; Stephan M; Hoffmann E; Unertl K; Krueger WA
    Int J Artif Organs; 2004 Jun; 27(6):473-9. PubMed ID: 15293354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
    Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
    Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.
    Boselli E; Breilh D; Caillault-Sergent A; Djabarouti S; Guillaume C; Xuereb F; Bouvet L; Rimmelé T; Saux MC; Allaouchiche B
    J Antimicrob Chemother; 2012 May; 67(5):1207-10. PubMed ID: 22351682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of linezolid in human serum by reversed-phase high-performance liquid chromatography with ultraviolet and diode array detection.
    Cios A; Kuś K; Szymura-Oleksiak J
    Acta Pol Pharm; 2013; 70(4):631-41. PubMed ID: 23923387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
    Malone RS; Fish DN; Abraham E; Teitelbaum I
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3148-55. PubMed ID: 11600370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings.
    Beringer P; Nguyen M; Hoem N; Louie S; Gill M; Gurevitch M; Wong-Beringer A
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3676-81. PubMed ID: 16127039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.
    Stalker DJ; Jungbluth GL
    Clin Pharmacokinet; 2003; 42(13):1129-40. PubMed ID: 14531724
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic studies of linezolid and teicoplanin in the critically ill.
    Whitehouse T; Cepeda JA; Shulman R; Aarons L; Nalda-Molina R; Tobin C; MacGowan A; Shaw S; Kibbler C; Singer M; Wilson AP
    J Antimicrob Chemother; 2005 Mar; 55(3):333-40. PubMed ID: 15705641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of oral bioavailability and preclinical pharmacokinetics of DRF-6196, a novel oxazolidinone analogue, in comparison to linezolid.
    Bhamidipati R; Venkatesh P; Dravid PV; Narasimhulu PC; Tvrs S; Das J; Mullangi R; Srinivas NR
    Eur J Drug Metab Pharmacokinet; 2005; 30(3):187-93. PubMed ID: 16250256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
    Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
    J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.